Some of these mechanisms, for instance, cell adhesion (Besson et al., 2008; Li, 2008), autophagy (Crotzer and Blum, 2009), cyclin-dependent kinase (CDK) inhibtion (Besson et al., 2008), and lysosomal membrane permeabilization (LMP)-induced cell death (Groth-Pedersen et al., 2007; Serrano-Puebla and Boya, 2018) were recently acclaimed as novel targets for tumor therapy. Here, PDLIM7 is linked to neoplasm.